患者エンゲージメントソリューションの世界市場予測(~2022年):ハードウェア、ソフトウェア、サービス

◆英語タイトル:Patient Engagement Solutions Market by Component (Hardware, Software, Services), Delivery mode (On-Premise, Cloud), End User (Provider, Payer), Applications (Home Health, Financial Health), Therapeutic Area - Global Forecast to 2022
◆発行会社/調査会社:MarketsandMarkets
◆商品コード:MAM-HIT-2767
◆発行日:2017年10月9日
◆調査対象地域:グローバル
◆産業分野:医療
◆ページ数:179
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール(受注後24時間以内)
◆販売価格オプション(消費税別)
Single User(1名利用)USD5,650 ⇒換算¥638,450見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥751,450見積依頼/購入/質問フォーム
Corporate License (同一法人内共有可)USD8,150 ⇒換算¥920,950見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarkets社の日本における正規販売代理店です。同社発行の市場調査資料のご購入、委託調査サービスに関するお問い合わせは弊社までお願い致します。
MarketsandMarkets社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[患者エンゲージメントソリューションの世界市場予測(~2022年):ハードウェア、ソフトウェア、サービス]についてメールでお問い合わせはこちら
MarketsandMarketsが発行した当調査レポートでは、患者エンゲージメントソリューションの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、構成要素別分析、導入方式別分析、用途別分析、地域別分析、患者エンゲージメントソリューションの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。
*** レポート概要(サマリー)***

“Patient engagement solutions market is projected to register a CAGR of 16.2%”The global patient engagement solutions market is estimated to register a CAGR of 16.2% from 2017 to 2022, to reach USD 18.68 billion. The key factors driving the growth of the overall patient engagement solutions market include the rise in aging population, increasing burden of chronic diseases and focus of patients on self-managing their care has led to an increase in the adoption of patient engagement solutions globally. However, in spite of the numerous benefits certain barriers such as security of patient data and lack of interoperability are restraining the growth of this market.

“The healthcare providers are projected to register the highest CAGR during the forecast period”
Based on end users, the patient engagement solutions market is segmented into healthcare providers, payers, individual users, and other end users (including government bodies, employer groups, and pharmaceutical companies). During the forecast period, the healthcare providers segment is expected to register the highest CAGR. This growth is mainly due to the increasing number of healthcare providers adopting patient engagement solutions to curtail the rising cost of healthcare, offer of value-based care to the population, and improve financial outcomes. Patient engagement solutions help providers to improve patient experience, meet the increasing demand for convenient access to health information, and better serve patients who are motivated to self-manage their care.

“Europe to witness the highest growth during the forecast period”
Europe is expected to register the highest CAGR in the global patient engagement solutions market for the forecast period of 2017–2022. The growing demand for advanced healthcare solutions and efficient healthcare delivery in Germany, role of NHS in the UK, implementation of the Dossier Médical Personnel (DMP) in France, and rising number of initiatives to improve care coordination in RoE are expected to drive the adoption of patient engagement solutions in these countries.

Break of primary participants was as mentioned below:
• By Company Type – Tier 1–85%, Tier 2–9%, and Tier 3–6%
• By Designation – C-level–81%, Director Level–10%, Others–9%
• By Region – North America–40%, Europe–20%, Asia-Pacific–29%, RoW–11%

Some of the major players in the patient engagement solutions market include McKesson Corporation (US), Allscripts (US), IBM (US), athenahealth (US), Cerner Corporation (US), and Orion Health (New Zealand).
Research Coverage:
The report analyzes the patient engagement solutions market and aims at estimating the market size and the future growth potential of this market based on various segments such as components, therapeutic area, application, end user, and region. The report also includes an in-depth regulatory analysis for various regions across the globe and competitive analysis of the key players in this market along with their company profiles, product and service offerings, recent developments, and key market strategies.
Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a greater share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies.

This report provides insights on the following pointers:
• Market Penetration: Comprehensive information on product and service portfolios offered by the top players in the market
• Service Enhancement/Innovation: Detailed insights on upcoming trends and service launches in the market
• Market Development: Comprehensive information about the lucrative emerging markets by component, delivery mode, end user, application, therapeutic area, and region
• Market Diversification: Exhaustive information about new services or service enhancements, growing geographies, recent developments, and investments in the market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, products, and services of leading players in the global market

*** レポート目次(コンテンツ)***

TABLE OF CONTENTS

1 INTRODUCTION 14
1.1 OBJECTIVES OF STUDY 14
1.2 MARKET DEFINITION 14
1.3 MARKET SCOPE 15
1.3.1 MARKETS COVERED 15
1.3.2 YEARS CONSIDERED FOR THE STUDY 16
1.4 CURRENCY 16
1.5 LIMITATIONS 16
1.6 STAKEHOLDERS 16

2 RESEARCH METHODOLOGY 17
2.1 RESEARCH DATA 17
2.2 SECONDARY RESEARCH 18
2.2.1 KEY DATA FROM SECONDARY SOURCES 18
2.3 PRIMARY RESEARCH 19
2.3.1 KEY DATA FROM PRIMARY SOURCES 20
2.3.2 KEY INSIGHTS FROM PRIMARY SOURCES 22
2.3.3 KEY INDUSTRY INSIGHTS 23
2.4 MARKET SIZE ESTIMATION METHODOLOGY 23
2.5 DATA VALIDATION & TRIANGULATION 27
2.6 ASSUMPTIONS FOR THE STUDY 28

3 EXECUTIVE SUMMARY 29

4 PREMIUM INSIGHTS 34
4.1 PATIENT ENGAGEMENT SOLUTIONS: MARKET SNAPSHOT 34
4.2 PATIENT ENGAGEMENT SOLUTIONS MARKET SHARE, BY REGION AND END USER 35
4.3 PATIENT ENGAGEMENT SOLUTIONS MARKET SHARE, BY THERAPEUTIC AREA
(2017 VS. 2022) 36
4.4 GEOGRAPHICAL SNAPSHOT: PATIENT ENGAGEMENT SOLUTIONS MARKET 37

5 MARKET OVERVIEW 38
5.1 INTRODUCTION 38
5.2 MARKET DYNAMICS 38
5.2.1 DRIVERS 39
5.2.1.1 Implementation of government regulations and initiatives to promote patient-centric care 39
5.2.1.2 Implementation of incentives to shift the burden of risk from healthcare payers to providers 40
5.2.1.3 Growing popularity of patient engagement solutions among the aging population 40
5.2.1.4 Significant investments in HCIT by stakeholders 41
5.2.1.5 Rising number of collaborations and partnerships between stakeholders 41
5.2.1.6 Increasing utilization of mobile health solutions 42
5.2.2 RESTRAINTS 43
5.2.2.1 Requirement of investments in infrastructure for implementing patient engagement solutions 43
5.2.2.2 Protection of patient information 43
5.2.2.3 Lack of interoperability 43
5.2.2.4 Dearth of skilled IT professionals in the healthcare industry 44
5.2.3 OPPORTUNITIES 44
5.2.3.1 Emerging asian countries 44
5.2.3.2 Growing medical tourism 45
5.2.3.3 Wearable health technology 45
5.2.3.4 Cloud-based models 45
5.2.4 CHALLENGES 46
5.2.4.1 High cost of deployment 46
5.2.4.2 Lack of health literacy 46
5.3 PATIENT ENGAGEMENT SOLUTIONS MARKET, PRICING ANALYSIS 47

6 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT 49
6.1 INTRODUCTION 50
6.2 HARDWARE 50
6.3 SOFTWARE 51
6.3.1 STANDALONE SOFTWARE 52
6.3.2 INTEGRATED SOFTWARE 53
6.4 SERVICES 54

7 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE 55
7.1 INTRODUCTION 56
7.2 ON–PREMISE SOLUTIONS 56
7.3 CLOUD-BASED SOLUTIONS 58

8 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER 59
8.1 INTRODUCTION 60
8.2 PROVIDERS 60
8.3 PAYERS 61
8.4 PATIENTS 62
8.5 OTHER END USERS 63

9 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION 65
9.1 INTRODUCTION 66
9.2 HEALTH MANAGEMENT 66
9.3 HOME HEALTH MANAGEMENT 67
9.4 SOCIAL AND BEHAVIORAL MANAGEMENT 68
9.5 FINANCIAL HEALTH MANAGEMENT 69

10 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA 70
10.1 INTRODUCTION 71
10.1.1 CHRONIC DISEASES 71
10.1.1.1 Diabetes 73
10.1.1.2 Cardiovascular diseases 73
10.1.1.3 Obesity 74
10.1.1.4 Other chronic diseases 75
10.1.2 WOMEN’S HEALTH 75
10.1.3 FITNESS 76
10.1.4 OTHER THERAPEUTIC AREAS 77

11 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY REGION 78
11.1 INTRODUCTION 79
11.2 NORTH AMERICA 80
11.2.1 US 84
11.2.2 CANADA 91
11.3 EUROPE 95
11.3.1 GERMANY 102
11.3.2 UK 104
11.3.3 FRANCE 107
11.3.4 REST OF EUROPE (ROE) 109
11.4 ASIA PACIFIC 112
11.5 REST OF THE WORLD 118

12 COMPANY PROFILES 122
(Overview, Products Offered, Product Offering Scorecard, Business Strategy Scorecard, Recent Developments)*
12.1 MCKESSON 122
12.2 ALLSCRIPTS 126
12.3 IBM 131
12.4 ATHENAHEALTH 135
12.5 ORION HEALTH 140
12.6 CERNER 144
12.7 GETWELLNETWORK 149
12.8 LINCOR SOLUTIONS 153
12.9 YOURCAREUNIVERSE 156
12.10 WELVU 159
12.11 GET REAL HEALTH 161
12.12 ONEVIEW HEALTHCARE 164

*Details on MarketsandMarkets view, Overview, Products Offered, Product Offering Scorecard, Business Strategy Scorecard, and Recent Developments might not be captured in case of unlisted companies.

13 APPENDIX 167
13.1 DISCUSSION GUIDE 167
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 172
13.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 174
13.4 AVAILABLE CUSTOMIZATIONS 175
13.5 RELATED REPORTS 176
13.6 AUTHOR DETAILS 177

LIST OF TABLES

TABLE 1 INDICATIVE LIST OF COLLABORATIONS BETWEEN ORGANIZATIONS FROM
2014–2017 41
TABLE 2 PRICING ANALYSIS OF PATIENT ENGAGEMENT SOLUTIONS 48
TABLE 3 GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT,
2015–2022 (USD BILLION) 50
TABLE 4 HARDWARE SOLUTIONS MARKET, BY REGION, 2015–2022 (USD MILLION) 51
TABLE 5 SOFTWARE SOLUTIONS MARKET, BY REGION, 2015–2022 (USD MILLION) 51
TABLE 6 SOFTWARE SOLUTIONS MARKET, BY TYPE, 2015–2022 (USD MILLION) 52
TABLE 7 STANDALONE SOFTWARE SOLUTIONS MARKET, BY REGION,
2015–2022 (USD MILLION) 52
TABLE 8 INTEGRATED SOFTWARE SOLUTIONS MARKET, BY REGION,
2015–2022 (USD MILLION) 53
TABLE 9 PATIENT ENGAGEMENT SERVICES MARKET, BY REGION,
2015–2022 (USD MILLION) 54
TABLE 10 GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE,
2015–2022 (USD BILLION) 56
TABLE 11 ON-PREMISE SOLUTIONS MARKET, BY REGION, 2017–2022 (USD MILLION) 57
TABLE 12 CLOUD-BASED SOLUTIONS MARKET, BY REGION, 2015–2022 (USD MILLION) 58
TABLE 13 GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER,
2015–2022 (USD BILLION) 60
TABLE 14 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS,
BY REGION, 2015–2022 (USD MILLION) 61
TABLE 15 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS,
BY REGION, 2015–2022 (USD MILLION) 62
TABLE 16 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PATIENTS,
BY REGION, 2015–2022 (USD MILLION) 63
TABLE 17 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER END USERS,
BY REGION, 2015–2022 (USD MILLION) 64
TABLE 18 GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION,
2015–2022 (USD BILLION) 66
TABLE 19 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HEALTH MANAGEMENT APPLICATIONS, BY REGION, 2015–2022 (USD MILLION) 67
TABLE 20 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HOME HEALTH MANAGEMENT APPLICATIONS, BY REGION, 2015–2022 (USD MILLION) 67
TABLE 21 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR SOCIAL AND BEHAVIORAL MANAGEMENT APPLICATIONS, BY REGION, 2015–2022 (USD MILLION) 68
TABLE 22 PATIENT ENGAGEMENT SOLUTIONS FOR FINANCIAL HEALTH MANAGEMENT APPLICATIONS, BY REGION, 2015–2022 (USD MILLION) 69
TABLE 23 GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2015–2022 (USD MILLION) 71
TABLE 24 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES,
BY REGION, 2015–2022 (USD MILLION) 72
TABLE 25 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES,
BY TYPE, 2015–2022 (USD MILLION) 72
TABLE 26 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR DIABETES, BY REGION,
2015–2022 (USD MILLION) 73
TABLE 27 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CARDIOVASCULAR DISEASES,
BY REGION, 2015–2022 (USD MILLION) 74
TABLE 28 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OBESITY, BY REGION,
2017–2022 (USD MILLION) 74
TABLE 29 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER CHRONIC DISEASES,
BY REGION, 2017–2022 (USD MILLION) 75
TABLE 30 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR WOMEN’S HEALTH,
BY REGION, 2015–2022 (USD MILLION) 76
TABLE 31 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR FITNESS, BY REGION,
2015–2022 (USD MILLION) 77
TABLE 32 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER THERAPEUTIC AREAS,
BY REGION, 2015–2022 (USD MILLION) 77
TABLE 33 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY REGION,
2015–2022 (USD BILLION) 79
TABLE 34 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET,
BY COUNTRY, 2015–2022 (USD MILLION) 80
TABLE 35 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET,
BY COMPONENT, 2015–2022 (USD MILLION) 82
TABLE 36 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET,
BY DELIVERY MODE, 2015–2022 (USD MILLION) 82
TABLE 37 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET,
BY END USER, 2015–2022 (USD MILLION) 83
TABLE 38 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET,
BY APPLICATION, 2015–2022 (USD MILLION) 83
TABLE 39 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET,
BY THERAPEUTIC AREA, 2015–2022 (USD MILLION) 84
TABLE 40 US: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT,
2015–2022 (USD MILLION) 89
TABLE 41 US: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE,
2015–2022 (USD MILLION) 89
TABLE 42 US: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER,
2015–2022 (USD MILLION) 90
TABLE 43 US: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION,
2015–2022 (USD MILLION) 90
TABLE 44 US: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA,
2015–2022 (USD MILLION) 91
TABLE 45 CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT,
2015–2022 (USD MILLION) 92
TABLE 46 CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2015–2022 (USD MILLION) 93
TABLE 47 CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER,
2015–2022 (USD MILLION) 93
TABLE 48 CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION,
2015–2022 (USD MILLION) 94
TABLE 49 CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2015–2022 (USD MILLION) 94
TABLE 50 INDICATIVE LIST OF EHEALTH PROJECTS UNDERTAKEN BY THE EUROPEAN UNION 96
TABLE 51 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 98
TABLE 52 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT,
2015–2022 (USD MILLION) 100
TABLE 53 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2015–2022 (USD MILLION) 100
TABLE 54 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER,
2015–2022 (USD MILLION) 100
TABLE 55 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION,
2015–2022 (USD MILLION) 101
TABLE 56 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2015–2022 (USD MILLION) 101
TABLE 57 GERMANY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT,
2015–2022 (USD MILLION) 102
TABLE 58 GERMANY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2015–2022 (USD MILLION) 103
TABLE 59 GERMANY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER,
2015–2022 (USD MILLION) 103
TABLE 60 GERMANY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION,
2015–2022 (USD MILLION) 103
TABLE 61 GERMANY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2015–2022 (USD MILLION) 104
TABLE 62 UK: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT,
2015–2022 (USD MILLION) 105
TABLE 63 UK: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE,
2015–2022 (USD MILLION) 105
TABLE 64 UK: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER,
2015–2022 (USD MILLION) 105
TABLE 65 UK: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION,
2015–2022 (USD MILLION) 106
TABLE 66 UK: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA,
2015–2022 (USD MILLION) 106
TABLE 67 FRANCE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT,
2015–2022 (USD MILLION) 107
TABLE 68 FRANCE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2015–2022 (USD MILLION) 108
TABLE 69 FRANCE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER,
2015–2022 (USD MILLION) 108
TABLE 70 FRANCE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION,
2015–2022 (USD MILLION) 108
TABLE 71 FRANCE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2015–2022 (USD MILLION) 109
TABLE 72 ROE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT,
2015–2022 (USD MILLION) 110
TABLE 73 ROE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE,
2015–2022 (USD MILLION) 110
TABLE 74 ROE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER,
2015–2022 (USD MILLION) 110
TABLE 75 ROE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION,
2015–2022 (USD MILLION) 111
TABLE 76 ROE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA,
2015–2022 (USD MILLION) 111
TABLE 77 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET,
BY COMPONENT, 2015–2022 (USD MILLION) 116
TABLE 78 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET,
BY DELIVERY MODE, 2015–2022 (USD MILLION) 116
TABLE 79 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET,
BY END USER, 2015–2022 (USD MILLION) 116
TABLE 80 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET,
BY APPLICATION, 2015–2022 (USD MILLION) 117
TABLE 81 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET,
BY THERAPEUTIC AREA, 2015–2022 (USD MILLION) 117
TABLE 82 ROW: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT,
2015–2022 (USD MILLION) 120
TABLE 83 ROW: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE,
2015–2022 (USD MILLION) 120
TABLE 84 ROW: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER,
2015–2022 (USD MILLION) 120
TABLE 85 ROW: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION,
2015–2022 (USD MILLION) 121
TABLE 86 ROW: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA,
2015–2022 (USD MILLION) 121


LIST OF FIGURES

FIGURE 1 GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET: RESEARCH METHODOLOGY STEPS 17
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 21
FIGURE 3 SAMPLING FRAME: PRIMARY RESEARCH 21
FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH 24
FIGURE 5 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 25
FIGURE 6 RESEARCH DESIGN 26
FIGURE 7 DATA TRIANGULATION 27
FIGURE 8 SERVICES SEGMENT TO REGISTER THE HIGHEST CAGR IN THE GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET BETWEEN 2017 & 2022 29
FIGURE 9 HEALTH MANAGEMENT SEGMENT TO HOLD THE LARGEST SHARE IN THE GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET BETWEEN 2017 & 2022 30
FIGURE 10 CLOUD-BASED SOLUTIONS TO REGISTER THE HIGHEST CAGR IN THE GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET BETWEEN 2017 & 2022 31
FIGURE 11 HEALTHCARE PROVIDERS DOMINATES THE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER (2017 VS 2022) 32
FIGURE 12 NORTH AMERICA DOMINATED THE PATIENT ENGAGEMENT SOLUTION MARKET DURING THE FORECAST PERIOD 33
FIGURE 13 GOVERNMENT REGULATIONS TO DRIVE MARKET GROWTH DURING THE FORECAST PERIOD 34
FIGURE 14 GERMANY & HEALTHCARE PROVIDERS TO DOMINATE PATIENT ENGAGEMENT SOLUTIONS MARKET IN EUROPE (2017) 35
FIGURE 15 CHRONIC DISEASES SEGMENT TO COMMAND THE LARGEST SHARE OF THE PATIENT ENGAGEMENT SOLUTIONS MARKET DURING THE FORECAST PERIOD 36
FIGURE 16 EUROPE TO WITNESS THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD 37
FIGURE 17 PATIENT ENGAGEMENT SOLUTIONS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 38
FIGURE 18 PATIENT ENGAGEMENT SOLUTIONS: COST COMPONENTS 47
FIGURE 19 NORTH AMERICA TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET IN 2017 79
FIGURE 20 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET SNAPSHOT 81
FIGURE 21 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET SNAPSHOT 99
FIGURE 22 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET SNAPSHOT 115
FIGURE 23 ROW: PATIENT ENGAGEMENT SOLUTIONS MARKET SNAPSHOT 119
FIGURE 24 MCKESSON: COMPANY SNAPSHOT 122
FIGURE 25 ALLSCRIPTS: COMPANY SNAPSHOT 126
FIGURE 26 IBM: COMPANY SNAPSHOT 131
FIGURE 27 ATHENAHEALTH: COMPANY SNAPSHOT 135
FIGURE 28 ORION HEALTH: COMPANY SNAPSHOT 140
FIGURE 29 CERNER: COMPANY SNAPSHOT 144


*** レポートのキーワード ***

患者エンゲージメントソリューション、ハードウェア、患者エンゲージメントソフトウェア、サービス

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(MAM-HIT-2767 )"患者エンゲージメントソリューションの世界市場予測(~2022年):ハードウェア、ソフトウェア、サービス" (英文:Patient Engagement Solutions Market by Component (Hardware, Software, Services), Delivery mode (On-Premise, Cloud), End User (Provider, Payer), Applications (Home Health, Financial Health), Therapeutic Area - Global Forecast to 2022)はMarketsandMarkets社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。